New Yakult Danone product to come in 2018; expects 20% sales growth

Firm will go for a 2nd India factory only if sales hit 800,000 bottles a day, says MD Minoru Shimada

Bs_logoMinoru Shimada, Yakult
Minoru Shimada, MD of Yakult Danone India Pvt Ltd. Photo: Subrata Majumder
Avishek Rakshit Kolkata
Last Updated : Sep 08 2017 | 3:58 PM IST
Expecting a revenue and sales volume growth rate of 20 per cent this year and in the coming few years, Yakult Danone India, a 50:50 joint-venture between Japan-based Yakult Honsha and Groupe Danone of France, will be coming out with a new probiotic product under the fermented milk category.

The company's managing director, Minoru Shimada, said that the new product was in the development phase and its Tokyo-based research and development facility was working on the product.

Since its entry into India in 2008, under the fermented milk category, the company has had only one product, which is priced at Rs 12 per bottle of 65 ml. At the same time, other dairy majors like Nestle, Mother Dairy, and Amul have successfully introduced probiotic curd and ice cream.

Shimada reasoned that the new product would be in the existing product category as it was not possible to offer the bacteria count used in its products in other product categories like curd or ice cream.

The company has claimed that it offers 6.5 billion bacteria in its product that is available in India. Also, in India, the company uses only the Lactobacillus casei strain Shirota variant of the benevolent bacteria whereas four different strains are used in its Japanese products.

The company has claimed that regular curd is not a probiotic as ordinary lactic acid bacteria, which is not proven to reach the stomach alive (upon consumption) and there is no scientific evidence of it being a probiotic, is present in this product.

"We are studying what kind of nutrients are lacking in India and what is the customer demand. Based on these, we will launch a new product," Shimada told Business Standard.

It is also scaling up its operations at its Sonepat facility in Haryana. Currently, running at a near 100 per cent capacity utilisation, the plant can roll out 200,000 bottles per day, which the probiotic maker will scale up to manufacture 280,000 bottles a day in the next two years.

Although faced with logistics costs owing to a single factory, Shimada is not keen to opt for a second one till he is able to sell at least 800,000 bottles a day from the current 200,000 bottles.

"Once we reach this minimum target, we'll come up with a second plant, either in Maharashtra or Karnataka," he added.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app